회사 소개
- 법인명: Samchundang Pharm. Co., Ltd
- 등록 국가: Republic of Korea
- 주소: 71, Jeyakgongdan2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
- 직원 수: 250 - 499
설명:
SamChunDang Pharm Co., Ltd. is a top Korean pharmaceutical company specializing in ophthalmic products, holding US and EU GMP certifications that position it as a leader in generic ophthalmic production. Its groundbreaking work includes developing a biosimilar for Eylea (Aflibercept), a macular degeneration treatment, earning industry recognition; SCD's vision extends beyond ophthalmology as it expands into non-ophthalmic fields including new drug delivery systems, oral GLP-1 and long-acting injections, aiming to revolutionize the global pharmaceutical industry.
사업 활동
완제 의약품
제조업체
바이오의약품
제조업체
오리지널 원료의약품
제조업체
주요 제품/서비스
- 완제 의약품: Sodium hyaluronate 0.1%, 0.18%, 0.3% Eye Drops (multi/mono dose), Olopatadine 0.1%, 0.2% Eye Drops, Latanoprost preservative-free Eye Drops (mono dose), Moxista Eye drops(Multi/Single Dose), Oloten Eye Drops(Multi/Single dose), Olotenplus Eye Drops(Multi/Single Dose), Tolon Eye Drops(Multi/Single Dose), Sodium Hyaluronate 0.15% Eye Drops(Multi/Single Dose), IrisPlus Eye Drops (disposable)
- 바이오의약품: Eylea biosimilar vial & PFS
- 오리지널 원료의약품: Brimonidne/Timolol Eye Drops
당사 제품 & 서비스
Sell · Finished Dosage Forms
인증
FDA
GMP
ISO
증거
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기